Catalyst Wire Dossier Catalyst Wire Dossier

IL-12 gene therapy

interleukin-12 gene therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL-12 gene therapy, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy [Phase 1]

See pricing